Healthcare Triangle approves reverse stock split measures
Healthcare Triangle, Inc. stockholders approve reverse stock splits to stabilize share price and comply with Nasdaq regulations.
Tempus AI, Inc. Secures $192.5 Million in Data Agreements
Tempus AI, Inc. announces $192.5 million agreements with Bristol-Myers Squibb and Pathos AI to enhance oncology and neurology data access.